DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Ruff CT, Giugliano RP, Antman EM. et al.
Evaluation of the novel factor Xa inhibitor edoxaban compared with warfarin in patients with atrial fibrillation: design and rationale for the Effective aNticoaGulation with factor xA next GEneration in Atrial Fibrillation-Thrombolysis In Myocardial Infarction study 48 (ENGAGE AF-TIMI 48).
Am Heart J 2010;
160 (04) 635-641
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.